Dr. Paul Offit, or as he is also known Paul “For Profit” Offit, is a fairly well-known and frequent commentator in favor of vaccinations who dismisses many vaccine risks and promotes vaccine mandates. But he is not just a doctor who believes that vaccinations save lives. Far from it.
Dr. Offit is also a listed inventor on a cluster of patents that protect Merck’s Rotateq vaccine and share the title “Rotavirus Reassortant Vaccine.” They include four granted U.S. patents — US5626851, US5750109, US6113910 and US6290968 — and two granted European patents — EP323708 and EP493575.
He is also the recipient of a $350,000 grant from Merck for the vaccine’s development, a consultant to Merck Pharmaceuticals and, the icing on the cake, previously served as a member of The Advisory Committee on Immunization Practices (ACIP).
ACIP is a 15-member panel of immunization experts, selected by the Secretary of the U.S. Department of Health and Human Services. They provide advice and guidelines to the Centers for Disease Control and Prevention (CDC) on vaccine-preventable diseases.
As a member of the ACIP from 1998 to 2003, Dr. Offit was involved in CDC recommendations about giving rotavirus vaccine to babies. He voted “yes” three times out of four on issues pertaining to the ACIP’s rotavirus use recommendation (including, voting for his own vaccine to be included in the immunization schedule).
To clarify, Dr. Offit voted for the FIRST Rotashield vaccine manufactured by Wyeth (monkey-human hybrid virus) approved by ACIP in 1998 to be given to all babies. He abstained from the vote in 1999 to recommend that Rotashield be removed from the market. He did not vote for the Merck Rotateq vaccine (cow-human hybrid virus) to be recommended for use in all babies — he was prevented under ACIP/government rules from voting to recommend a product he had a personal financial stake in.
Now, as a result of Merck’s rotavirus vaccine being added to the CDC’s childhood vaccination schedule, the value of Dr. Offit’s stake in the vaccine has skyrocketed.
Should this guys still working with children?